Corona Remedies

Why is Corona Remedies Ltd falling/rising?

As of 17-Mar, the stock price of Corona Remedies Ltd is rising to 1,566.50, driven by recent gains, increased investor participation, and favorable technical indicators. The stock has outperformed its sector and shows heightened interest among investors.

As of 17-Mar, the stock price of Corona Remedies Ltd is rising, currently at 1,566.50, with a change of 14.15 (0.91%) upward. This increase can be attributed to several factors. Firstly, the stock has been gaining for the last two days, resulting in a total return of 1.99% during this period. Additionally, it has outperformed its sector by 0.63% today, indicating stronger performance relative to its peers.<BR><BR>Moreover, there has been a significant rise in investor participation, as evidenced by a delivery volume of 80.74k on 16 March, which is an increase of 460.38% compared to the 5-day average delivery volume. This surge in trading activity suggests heightened interest and confidence among investors.<BR><BR>In terms of technical indicators, the stock's price is currently higher than the 50-day, 100-day, and 200-day moving averages, which typically signals a positive trend. However, it is lower than the 5-day and 20-day moving averages, indicating some short-term fluctuations. Overall, the combination of recent gains, increased investor participation, and favorable moving averages contributes to the rising stock price of Corona Remedies Ltd.

Why is Corona Remedies Ltd falling/rising?

As of 18-Mar, Corona Remedies Ltd's stock price is at Rs 1,639.25, up 4.78%, outperforming the market with a year-to-date increase of 18.28%. The stock has shown strong investor interest, indicated by a 59.23% rise in delivery volume, suggesting confidence in its future performance.

As of 18-Mar, Corona Remedies Ltd's stock price is rising, currently at Rs 1,639.25, reflecting an increase of Rs 74.85 or 4.78%. This upward movement can be attributed to several factors. Over the past week, the stock has gained 1.84%, while the benchmark Sensex has decreased by 0.21%, indicating that Corona Remedies is outperforming the market. In the last month, the stock has risen by 3.33%, contrasting sharply with the Sensex's decline of 8.40%. Year-to-date, the stock has shown a robust increase of 18.28%, while the Sensex has fallen by 9.99%.<BR><BR>Today's performance is particularly noteworthy, as the stock has outperformed its sector by 4.51%. It has also been on a consecutive gain streak for the last three days, accumulating a total return of 6.72% during this period. The stock reached an intraday high of Rs 1,665, marking a 6.43% increase. Additionally, it is trading above all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), which is a positive technical indicator.<BR><BR>Investor interest appears to be rising, as evidenced by a significant increase in delivery volume, which rose by 59.23% compared to the 5-day average. This suggests that more investors are willing to hold the stock rather than trade it, indicating confidence in its future performance. Overall, these factors contribute to the stock's rising price.

Why is Corona Remedies Ltd falling/rising?

As of 19-Mar, the stock price of Corona Remedies Ltd is Rs 1,615.00, down 0.95% after three days of gains. Despite this recent decline, the stock has shown positive performance over the longer term, outperforming the Sensex, but is currently affected by sector declines and reduced investor participation.

As of 19-Mar, the stock price of Corona Remedies Ltd is currently at Rs 1,615.00, reflecting a decrease of Rs 15.5 or 0.95%. This decline follows a trend reversal after three consecutive days of gains. The stock has also touched an intraday low of Rs 1,588, which represents a drop of 2.61%. <BR><BR>Despite the current decline, the stock has shown positive performance over various periods, including a 1-week increase of 1.54% and a year-to-date rise of 16.53%, significantly outperforming the Sensex, which has fallen by 12.92% in the same timeframe. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend in the longer term.<BR><BR>However, there are negative indicators contributing to the current price drop. The Pharmaceuticals & Drugs sector has seen a decline of 2.13%, and there has been a notable decrease in investor participation, with delivery volume falling by 44.56% compared to the 5-day average. This reduced activity may be impacting the stock's price negatively.<BR><BR>In summary, while Corona Remedies Ltd has performed well over the longer term, the recent price drop can be attributed to a combination of sector-wide declines, reduced investor participation, and a trend reversal after previous gains.

Why is Corona Remedies Ltd falling/rising?

As of 20-Mar, Corona Remedies Ltd's stock price is rising to Rs 1,639.00, up 2.41%, supported by strong performance against the Sensex. Despite a significant drop in investor participation, the stock shows bullish trends and remains liquid, reflecting positive market sentiment.

As of 20-Mar, Corona Remedies Ltd's stock price is rising, currently at Rs 1,639.00, which reflects an increase of Rs 38.55 or 2.41%. This upward movement is supported by several factors. Over the past week, the stock has gained 6.71%, significantly outperforming the Sensex, which saw a slight decline of 0.04%. In the past month, the stock has risen by 7.87%, while the Sensex has dropped by 10.00%. Year-to-date, Corona Remedies has shown a robust increase of 18.27%, contrasting with the Sensex's decline of 12.54%. <BR><BR>Today, the stock opened with a notable gain of 4.5% and reached an intraday high of Rs 1,672.45, indicating strong investor interest. Additionally, the stock is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bullish trend. However, it is worth noting that there has been a significant drop in investor participation, with delivery volume falling by 76.9% compared to the 5-day average, which could indicate a potential concern for future trading activity. Despite this, the stock remains liquid enough for trading, suggesting that the current rise is driven by positive market sentiment and performance relative to benchmarks.

Why is Corona Remedies Ltd falling/rising?

As of 23-Mar, Corona Remedies Ltd's stock price is currently 1,580.95, reflecting a decline of 3.88%. Despite outperforming the Sensex over the past week, the stock has underperformed its sector today and shows a significant drop in investor participation.

As of 23-Mar, Corona Remedies Ltd's stock price is falling, currently at 1,580.95, which reflects a decrease of 63.75 or 3.88%. This decline is occurring despite the stock having outperformed the benchmark Sensex over the past week, with a gain of 1.84% compared to the Sensex's drop of 3.72%. However, the stock's performance over the past month shows a slight decrease of 0.09%, while the Sensex has fallen by 12.72%. <BR><BR>Today, the stock has underperformed its sector, which has seen a decline of 3.62%. Additionally, the stock reached an intraday low of Rs 1579.25, marking a decrease of 3.98%. There is also a notable drop in investor participation, with delivery volume on March 20 falling by 75.79% compared to the 5-day average. Despite trading above its moving averages for 5, 20, 50, 100, and 200 days, the overall market sentiment appears to be negative, contributing to the stock's current decline.

Why is Corona Remedies Ltd falling/rising?

As of 24-Mar, Corona Remedies Ltd's stock price is at 1,565.20, down 1.22% and has declined 4.83% over the last two days due to reduced investor participation and underperformance against its sector. Despite trading above longer-term moving averages, it shows short-term weakness, reflected by a significant drop in trading volume.

As of 24-Mar, Corona Remedies Ltd's stock price is currently at 1,565.20, reflecting a decrease of 19.3 points or 1.22%. The stock has been experiencing a downward trend, having underperformed its sector by 2.34% today and has fallen consecutively for the last two days, resulting in a total decline of 4.83% during this period. <BR><BR>Despite opening with a gain of 2.18% today and reaching an intraday high of Rs 1,632, the overall performance has been negatively impacted by a significant drop in investor participation, with delivery volume on 23 March falling by 62.66% compared to the 5-day average. This decline in trading activity suggests reduced interest from investors, contributing to the stock's downward movement.<BR><BR>Additionally, while the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages, indicating a short-term weakness. Overall, the combination of recent price declines, reduced trading volume, and underperformance relative to the sector are key factors contributing to the falling stock price of Corona Remedies Ltd.

Why is Corona Remedies Ltd falling/rising?

As of 25-Mar, the stock price of Corona Remedies Ltd is slightly rising at 1,573.20, but it has underperformed its sector today and shows mixed signals in moving averages. Despite a year-to-date increase of 13.52%, recent declines and reduced investor participation may hinder sustained growth.

As of 25-Mar, the stock price of Corona Remedies Ltd is rising slightly, with a current price of 1,573.20, reflecting a change of 0.4 (0.03%) upward. This increase comes after a trend reversal, as the stock has gained after two consecutive days of decline. However, it is important to note that the stock has underperformed its sector by 1.86% today, indicating some challenges in maintaining momentum.<BR><BR>In terms of performance over different periods, the stock has shown a year-to-date increase of 13.52%, contrasting with a decline of 11.67% in the Sensex, suggesting that it has been performing relatively well in the longer term despite recent fluctuations. Nevertheless, the stock has experienced a decline of 3.51% over the past week and 2.91% over the past month, which may contribute to investor caution.<BR><BR>Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 28.02% compared to the 5-day average, which could indicate reduced interest or confidence among investors. The stock's moving averages show that it is currently higher than the 50-day, 100-day, and 200-day moving averages, but lower than the 5-day and 20-day moving averages, suggesting mixed signals regarding its short-term performance.<BR><BR>Overall, while the stock is experiencing a slight rise today, the context of recent underperformance and declining investor participation may temper the outlook for sustained growth.

Which are the latest news on Corona Remedies?